295 related articles for article (PubMed ID: 17785986)
1. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
[TBL] [Abstract][Full Text] [Related]
2. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
3. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
6. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus.
Sutton IJ; Fursdon Davis CJ; Esiri MM; Hughes S; Amyes ER; Vincent A
Ann Neurol; 2001 Feb; 49(2):253-7. PubMed ID: 11220746
[TBL] [Abstract][Full Text] [Related]
7. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
9. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
10. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
Ogita S; Llaguna OH; Feldman SM; Blum R
Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
[TBL] [Abstract][Full Text] [Related]
13. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung.
Bruylant K; Crols R; Humbel RL; Appel B; De Deyn PP
Clin Neurol Neurosurg; 2006 Jun; 108(4):415-7. PubMed ID: 16644410
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
15. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
[TBL] [Abstract][Full Text] [Related]
16. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
[TBL] [Abstract][Full Text] [Related]
17. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
18. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
[TBL] [Abstract][Full Text] [Related]
19. Anti-Yo antibody associated with occult fallopian tube carcinoma.
Selby KJ; Warner J; Klempner S; Konstantinopoulos PA; Hecht JL
Int J Gynecol Pathol; 2011 Nov; 30(6):536-8. PubMed ID: 21979588
[TBL] [Abstract][Full Text] [Related]
20. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
Finsterer J; Voigtländer T; Grisold W
J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]